Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOME-HP: Serodiagnosis of Domestic Hypersensitivity Pneumonitis
NCT05704218Not yet recruiting
- Sponsor
- CHU de Besançon
- Start
- Feb 2023
- Primary completion
- Mar 2026
01
Overview
Open-label, single-arm trial, sponsored by CHU de Besançon. Primary endpoints: Measurement of mold sensitization at 2 years, Measurement of mold presence in dwellings at 2 years and 1 more. Planned start Feb 2023; status: not yet recruiting.
Beyond the preview
Go deeper on NCT05704218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05704218.